Adeno‐associated virus 8‐mediated gene therapy for choroideremia: preclinical studies in in vitro and in vivo models
Open Access
- 1 May 2014
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 16 (5-6) , 122-130
Abstract
Background: Choroideremia (CHM) is a slowly progressive X‐linked retinal degeneration that results in a loss of photoreceptors, retinal pigment epithelium and choroid. CHM, the gene implicated in choroideremia, encodes Rab escort protein‐1 (REP‐1), which is involved in the post‐translational activation via prenylation of Rab proteins.Methods: We evaluated AAV8.CBA.hCHM, a recombinant adeno‐associated virus serotype 8 (rAAV8) vector, which targets retinal cells efficiently, for both therapeutic effect and safety in vitro and in vivo in a murine model. In vitro studies included western blot analyses and prenylation assays. In vivo studies included ophthalmoscopy, pupillometry, histology and immunofluorescence analysis.Results: Infection with AAV8.CBA.hCHM induced the expression of REP‐1 protein in a dose‐responsive fashion. Transduction with AAV8.CBA.hCHM reverses the biochemical and pathogenetic defects in CHM both in vitro and in vivo and showed no safety concerns in the in vivo investigations performed in the present study.Conclusions: AAV8 is a promising vector for human clinical gene therapy trials for choroideremia. Copyright © 2014 John Wiley & Sons, Ltd.Keywords
Funding Information
- Foundation Fighting Blindness (TA-GT-1211-0564-UPA-WG)
- Choroideremia Research Foundation
- F.M. Kirby Foundation
- Mackall Foundation Trust
- Penn Genome Frontiers Institute
- Research to Prevent Blindness
This publication has 37 references indexed in Scilit:
- Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophiesJournal of Clinical Investigation, 2010
- Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trialThe Lancet, 2009
- Subretinal delivery of adeno‐associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent miceThe Journal of Gene Medicine, 2009
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Novel AAV serotypes for improved ocular gene transferThe Journal of Gene Medicine, 2008
- Multiple Factors Contribute to Inefficient Prenylation of Rab27a in Rab Prenylation DiseasesJournal of Biological Chemistry, 2003
- Prenylation of Rab GTPases: molecular mechanisms and involvement in genetic diseaseFEBS Letters, 2001
- A practical diagnostic test for choroideremiaOphthalmology, 1998
- Deficient Geranylgeranylation of Ram/Rab27 in ChoroideremiaJournal of Biological Chemistry, 1995